OUR PIPELINE

Pre-clinical
Phase 1
Phase 2
Phase 3
Our Partner
Hematology
Loncastuximab Tesirine (ADCT-402, Lonca)
Pivotal Phase 2
Diffuse large B-cess lymphoma
Pivotal Phase 2
Diffuse large B-cess lymphoma & Mantle cell lymphoma, combination with ibrutinib
Phase 1b
Follicular lymphoma
ADCT-602
Phase 1a
Acute lymphoblastic leukemia
ALLO-715
Phase 1
Multiple myeloma
Preclinical
Multiple myeloma, combination with nirogacestat
ALIO-605
Preclinical
Multiple myeloma
ALLO-316
Preclinical
Acute myeloid leukemia
ALIO-819
Preclinical
Acute myeloid leukemia
Solid Tumor
ADCT-601
Phase 1a
Various solid tumors
ADCT-901
Preclinical
Various solid tumors
ALLO-316
Preclinical
Renal cell carcinoma
DLL3
Preclinical
Small cell lung cancer
Lymphodepletion
ALLO-647
Phase 1
Lymphodepletion